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BACKGROUND: As part of EUROCAT’s surveillance of congenital anomalies in Europe, a statistical monitor-
ing system has been developed to detect recent clusters or long-term (10 year) time trends. The purpose of
this article is to describe the system for the identification and investigation of 10-year time trends, conceived
as a ‘‘screening’’ tool ultimately leading to the identification of trends which may be due to changing terato-
genic factors. METHODS: The EUROCAT database consists of all cases of congenital anomalies including
livebirths, fetal deaths from 20 weeks gestational age, and terminations of pregnancy for fetal anomaly. Mon-
itoring of 10-year trends is performed for each registry for each of 96 non-independent EUROCAT congenital
anomaly subgroups, while Pan-Europe analysis combines data from all registries. The monitoring results are
reviewed, prioritized according to a prioritization strategy, and communicated to registries for investigation.
Twenty-one registries covering over 4 million births, from 1999 to 2008, were included in monitoring in
2010. CONCLUSIONS: Significant increasing trends were detected for abdominal wall anomalies, gastroschi-
sis, hypospadias, Trisomy 18 and renal dysplasia in the Pan-Europe analysis while 68 increasing trends were
identified in individual registries. A decreasing trend was detected in over one-third of anomaly subgroups
in the Pan-Europe analysis, and 16.9% of individual registry tests. Registry preliminary investigations indi-
cated that many trends are due to changes in data quality, ascertainment, screening, or diagnostic methods.
Some trends are inevitably chance phenomena related to multiple testing, while others seem to represent
real and continuing change needing further investigation and response by regional/national public health
authorities. Birth Defects Research (Part A) 91:S31–S43, 2011.  2011 Wiley-Liss, Inc.
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INTRODUCTION
EUROCAT is a network of population-based registries
for the epidemiologic surveillance of congenital anoma-
lies in Europe established in 1979 in the wake of the tha-
lidomide epidemic. The desire to prevent another thali-
domide tragedy by detection of any new teratogenic
drug or indeed any teratogenic environmental chemicals
(EUROCAT, 2004) is related to the following EUROCAT
objectives: to provide essential epidemiologic information
on congenital anomalies in Europe; to facilitate the early
warning of new teratogenic exposures; and to act as an
information and resource center for the population,
health professionals, and managers regarding clusters,
exposures, or risk factors of concern. Statistical monitor-
ing is one of the activities contributing to surveillance of
teratogenic exposures. It is primarily performed to detect
any previously unrecognized or unusual changes in fre-
quency of congenital anomalies over both the short and
long term which may indicate potential cause for concern
where there is no specific prior hypothesis about expo-
sure. It is also used in conjunction with other approaches
where there are specific hypotheses-driven questions
(e.g., whether neural tube defects [NTDs] are decreasing
due to rising of periconceptional folic acid status). It is
essentially a screening method to scrutinize data regu-
larly and systematically, and hence is also useful as a
data quality control system.
EUROCAT Central Registry performs annual statistical
monitoring for clusters within the most recent 2-year pe-
riod, short-term trends (5 years), and long-term trends
(10 years), with a protocol and reporting process for pre-
liminary investigation of clusters and trends (EUROCAT,
2010a, EUROCAT, 2010b). In this article, we describe the
EUROCAT statistical monitoring system for the detection
and investigation of long-term (10 year) trends in congen-
ital anomalies illustrated with data from the most recent
monitoring period, from 1999 to 2008.
METHODS
Data
The EUROCAT database consists of all cases of con-
genital anomalies notified by member registries including
liveborn cases, cases resulting in fetal deaths from 20
weeks gestation, and cases that were terminated after
prenatal diagnosis of a congenital anomaly (EUROCAT
Report 9, Paper 1). One case can have up to nine malfor-
mation or syndrome codes, coded to World Health Orga-
nization International Classification of Diseases (ICD)-
British Pediatric Association (ICD10, Q chapter; ICD9,
740–759). The EUROCAT Data Management Program
(EDMP) automatically assigns all cases of congenital
anomaly to one or more of the 96 EUROCAT congenital
anomaly subgroups (EUROCAT, 2005). Each major organ
subgroup (shown in gray in Table 1) is made up of a
hierarchical structure of subgroups (e.g., spina bifida
within NTDs within the nervous system). One case can
be assigned to more than one subgroup, but each case is
only counted once within any subgroup. Cases with
chromosomal anomalies are only included in the moni-
toring of chromosomal subgroups as chromosomal
anomalies are etiologically different from non-chromo-
somal anomalies.
Statistical monitoring for 10-year trends is conducted
centrally for full member registries that transmit anony-
mized individual data by the annual transmission dead-
line of February 15 of each year (leaving a full year
elapsed from the year of birth to cover late diagnoses
and registration processes). In 2010, 21 eligible registries
covering a total of 600,000 births per annum transmitted
data to 2008 (19 registries) or 2007 (2 registries). Regis-
tries varied in size from a coverage of 4000 to 74,000
births per year.
Statistical Methods for the Detection of Trends
Tests for trend are performed for each congenital anom-
aly subgroup for each registry based on the number of
cases per year of birth and number of births per year. The
major organ subgroups are included in the monitoring
mainly for tracking of data quality rather than for their in-
terest in relation to teratogens, since they tend to be very
heterogeneous. A ‘‘Pan-Europe’’ analysis additionally adds
all registries together into one single European average fig-
ure (without weighting). Years are grouped into 2-year
intervals. A trend test is not performed on a congenital
anomaly subgroup if the expected number of cases per 2-
year interval is <5 and if the observed number of cases in
any 2-year interval is <2.
Change over time is tested using the Cochran–Armitage
test that tests for trends in binomial proportions as
described by Agresti (2002). The test is divided into the
trend component (‘‘test for trend’’) and a component for
departure from linear trend (‘‘test for non-linear change’’).
The test for trend identifies evidence of an increasing or
decreasing trend in prevalence. The test for non-linear
change identifies change over time that is not linear.
As these analyses by the Central Registry are designed
to flag potentially changing patterns of prevalence in spe-
cific anomalies, which are unusual enough for further
investigation by local registries, no adjustment is made
for multiple hypothesis testing.
For simplicity of reporting, results are classified as fol-
lows:
 No significant change in prevalence over time: p 
0.05 for both linear and non-linear components.
 Significant increasing or decreasing trend: p < 0.05
for trend and p  0.01 for non-linear change.
 Significant non-linear change: p < 0.05 for non-linear
change and p > 0.05 for trend; or p < 0.01 for non-linear
change and p < 0.05 for trend.
For Down syndrome, an additional analysis corrects for
maternal age and in utero survival (EUROCAT, 2010a).
Each registry receives an Excel file (Microsoft, Red-
mond, WA) of the output showing the number of cases
and test for trend results per subgroup (EUROCAT,
2010a), as well as a file with graphical representation of
the congenital anomaly subgroups with statistically ‘‘sig-
nificant’’ change over time showing the rate of change
for significant linear trends. Centrally, all results are pre-
sented in a single summary spreadsheet to facilitate the
identification of patterns across registries or across sub-
groups.
All statistical tests and output are programmed in the
EDMP and thus available to member registries so that
they can conduct monitoring earlier, or conduct monitor-
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Table 1
Results of Pan-Europe Monitoring, 21 Registries, 1999 to 2008
Prevalence Non-linear change Trend
Anomaly Total
per 10,000
births Prob Prob Slope
% change/
2 years
Trend
description
All non-chromosomal anomalies 84,529 202.12 0.004 <0.001 NLC
Nervous system 9361 22.38 <0.001 Decreasing 3.2 DT
NTDs 4035 9.65 <0.001 Decreasing 4.5 DT
Anencephalus and similar 1570 3.75 0.003 Decreasing 4.0 DT
Encephalocele 482 1.15 NS
Spina bifida 1983 4.74 <0.001 Decreasing 5.7 DT
Hydrocephaly 2170 5.19 NS
Microcephaly 1000 2.39 <0.001 0.003 NLC
Arhinencephaly/holoprosencephaly 368 0.88 NS
Eye 1669 3.99 <0.001 Decreasing 8.4 DT
Anophthalmos/micropthalmos 357 0.85 0.008 Decreasing 7.4 DT
Anophthalmos 85 0.20 NS
Congenital cataract 440 1.05 NS
Congenital glaucoma 110 0.26 NS
Ear, face, and neck 852 2.04 0.042 <0.001 Decreasing 11.6 DT
Anotia 110 0.26 NS
CHD 25,308 60.52 <0.001 <0.001 NLC
Severe CHD* 7369 17.62 <0.001 Decreasing 3.2 DT
Common arterial truncus 255 0.61 NS
Transposition of great vessels 1394 3.33 0.009 Decreasing 3.4 DT
Single ventricle 255 0.61 <0.001 Decreasing 8.3 DT
Ventricular septal defect 11,109 26.56 <0.001 <0.001 NLC
Atrial septal defect 6041 14.45 <0.001 <0.001 NLC
Atrioventricular septal defect 790 1.89 0.009 Decreasing 4.8 DT
Tetralogy of Fallot 1211 2.90 NS
Tricuspid atresia and stenosis 347 0.83 <0.001 <0.001 NLC
Ebstein’s anomaly 191 0.46 NS
Pulmonary valve stenosis 1695 4.05 0.004 NLC
Pulmonary valve atresia 374 0.89 0.031 NLC
Aortic valve atresia/stenosis* 425 1.02 0.004 Decreasing 7.4 DT
Hypoplastic left heart 1051 2.51 NS
Hypoplastic right heart* 145 0.35 0.018 0.005 Decreasing 8.1 DT
Coarctation of aorta 1459 3.49 0.006 Decreasing 3.8 DT
Total anomalous pulmonary venous
return
239 0.57 NS
Respiratory 2275 5.44 0.039 <0.001 Decreasing 5.4 DT
Choanal atresia 297 0.71 NS
Cystic adenomatous malf of lung* 341 0.82 NS
Oro-facial clefts 6083 14.55 0.019 NLC
Cleft lip with or without palate 3624 8.67 NS
Cleft palate 2459 5.88 0.021 Decreasing 2.4 DT
Digestive system 6802 16.26 <0.001 <0.001 NLC
Esophageal atresia with/ without
tracheo-esophageal fistula
906 2.17 <0.001 Decreasing 6.1 DT
Duodenal atresia or stenosis 377 0.90 NS
Atresia or stenosis of other parts of
small intestine
356 0.85 NS
Anorectal atresia and stenosis 1197 2.86 0.019 Decreasing 3.7 DT
Hirschsprung’s disease 484 1.16 0.004 Decreasing 6.2 DT
Atresia of bile ducts 127 0.30 0.001 Decreasing 12.6 DT
Annular pancreas 53 0.13 NS
Diaphragmatic hernia 1067 2.55 0.01 Decreasing 4.1 DT
Abdominal wall defects 2298 5.49 0.026 Increasing 2.9 IT
Gastroschisis 1248 2.98 0.029 0.001 Increasing 6.0 IT
Omphalocele 915 2.19 NS
Urinary 13,251 31.69 <0.001 Decreasing 5.3 DT
Bilateral renal agenesis including
Potter syndrome
570 1.36 0.004 Decreasing 5.3 DT
Renal dysplasia 1820 4.35 0.013 Increasing 3.8 IT
Congenital hydronephrosis 5198 12.43 <0.001 Decreasing 6.8 DT
Bladder exstrophy and/or epispadia 259 0.62 NS
Posterior urethral valve and/or
prune belly
461 1.10 <0.001 Decreasing 7.1 DT
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ing for sub-areas of their registry population. An
important criterion in choice of statistical test was the
ability to incorporate it into the EDMP written in Access
(Microsoft, Redmond, WA, USA), so that monitoring,
including standard reports of results, can be run ‘‘at the
push of a button’’.
Central Coordination and Timetable
Central Registry runs the monitoring in March each year
(Fig. 1). The results are reviewed by the Steering Commit-
tee as per the prioritization strategy (below) to identify pos-
sible areas of concern and to direct central and local regis-
try investigations. The results are then sent to registries for
investigation, with preliminary investigations completed
by the Registry Leaders Meeting in early June. Investiga-
tion Reports are sent back to the Central Registry to com-
pile into the Annual Statistical Monitoring Report
(EUROCAT, 2010b). All investigation reports, including
investigations of clusters or trends that were detected
locally using more up-to-date data (Fig. 1), are included in
the annual Statistical Monitoring Report, which is sent to
European Union (EU) DGSanco and made openly available
on the EUROCAT website. The responsibility for dissemi-
nating the report (or local extracts) to regional or national
health authorities lies with the local registries.
Prioritization Strategy
Inevitably, repeated annual monitoring will increase
many chance findings. Rather than adjust these statistically
Table 1
Results of Pan-Europe Monitoring, 21 Registries, 1999 to 2008 (continued)
Prevalence Non-linear change Trend
Anomaly Total
per 10,000
births Prob Prob Slope
% change/
2 years
Trend
description
Genital 7156 17.11 0.035 NLC
Hypospadias 5763 13.78 0.028 Increasing 1.8 IT
Indeterminate sex 315 0.75 NS
Limb 15,526 37.13 0.039 <0.001 Decreasing 5.0 DT
Limb reduction 2319 5.55 <0.001 Decreasing 4.3 DT
Upper limb reduction 1593 3.81 0.039 Decreasing 2.8 DT
Lower limb reduction 856 2.05 0.002 Decreasing 5.2 DT
Complete absence of a limb 77 0.18 NS
Club foot – talipes equinovarus 4378 10.47 NS
Hip dislocation and/or dysplasia 2912 6.96 0.016 <0.001 Decreasing 7.9 DT
Polydactyly 3283 7.85 0.003 Decreasing 2.7 DT
Syndactyly 1973 4.72 0.01 <0.001 NLC
Arthrogryposis multiplex congenital 288 0.69 0.01 Decreasing 6.6 DT
Musculo-skeletal 3921 9.38 <0.001 <0.001 NLC
Thanatophoric dwarfism 141 0.34 NS
Jeune’s syndrome 57 0.14 NS
Achondroplasia 174 0.42 NS
Craniosynostosis 733 1.75 NS
Congenital constriction bands/
amniotic band
301 0.72 NS
Other malformations 2971 7.10 <0.001 <0.001 NLC
Asplenia 67 0.16 0.013 0.03 Decreasing 8.3 DT
Situs inversus 252 0.60 NS
Conjoined twins 83 0.20 NS
Disorders of skin 1187 2.84 0.012 <0.001 Decreasing 16.7 DT
Teratogenic syndromes with
malformations*
402 0.96 NS
Fetal alcohol syndrome* 78 0.19 0.017 Decreasing 15.0 DT
Valproate syndrome* 26 0.06 0.046 NLC
Warfarin syndrome* 4 0.01 Too few cases
Maternal infections resulting in
malformations
234 0.56 NS
Genetic syndromes 1 microdeletions 2782 6.65 0.006 <0.001 NLC
Chromosomal 16008 38.28 0.003 0.004 NLC
Down syndrome 8753 20.93 0.035 NLC
Down syndrome adjusted 8250 19.73 <0.001 NLC
Patau syndrome/Trisomy 13 829 1.98 NS
Edward syndrome/Trisomy 18 2099 5.02 0.014 Increasing 3.4 IT
Turner’s syndrome 1123 2.69 0.001 Decreasing 4.6 DT
Klinefelter’s syndrome 416 0.99 NS
Cri-du-chat syndrome 57 0.14 NS
Wolf–Hirschhorn syndrome 67 0.16 NS
*Not all registries included for the complete time period as subgroup only coded in ICD10 and some registries used ICD9 coding in
earlier years of monitoring period.
Prob, probability; NLC, non-linear change; NTDs, neural tube defects; DT, decreasing trend; NS, not significant; CHD, congenital heart
defect; IT, increasing trend.
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for multiple testing, a prioritization strategy is used
to prioritize trends considered most worthy of investiga-
tion:
Examine Pan-Europe results with significant findings.
 Prioritize increasing trends over decreasing trends,
and prioritize decreasing trends over non-linear change.
 Prioritize strong trends over weak trends, in terms
of slope/percentage change, and prioritize low p
values.
 Prioritize trends with evidence of consistency across
individual registries.
 Differentiate between new and continuing trends
(compared to previous year’s monitoring).
 Prioritize trends where there is prior concern about
change in frequency of the anomaly or a potentially
related exposure.
 Prioritize well-defined subgroups over major organ
system or heterogeneous subgroups.
Examine all individual registry significant results.
 Identify registries with many subgroup trends that
may reflect changes in overall ascertainment.
 Prioritize increasing trends as above.
 Prioritize investigation of individual registry trends
that correspond to significant Pan-Europe findings.
 Prioritize continuing trends (since previous year’s sta-
tistical monitoring) which seem robust to repeated analysis.
 Prioritize strong trends over weak trends, in terms of
slope/percentage change, and prioritize lower p values.
 Prioritize trends which take the registry prevalence
away from the EUROCAT average rather than trends
which seem to ‘‘normalize’’ the registry.
Guidelines for Local Registry Preliminary
Investigations
EUROCAT provides registries with guidelines on
how to conduct preliminary investigations of identified
long-term trends, as well as short-term trends and clus-
ters (guidelines available in the online Appendix; and in
Protocol, EUROCAT, 2010a). Investigations include case
verification; and verification of changes in diagnostic or
notification methods in the region. A template was
designed to simplify reporting and classification of the
results of preliminary investigations, (EUROCAT,
2010a).
The level of investigation is subject to available local
resources and varies between registries. Some registries
do extensive checking and cross-referencing registry data
with hospital records, while others are unable to do
this due to patient confidentiality issues or insufficient
resources.
Figure 1. Timeline of EUROCAT Statistical Monitoring.
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RESULTS
Detection of Trends
Pan-Europe trend tests were performed for 95 of the 96
subgroups of congenital anomalies included in central
monitoring for 21 registries combined covering 4.2 mil-
lion births, from 1999 to 2008, with the adjusted Down
syndrome results added (Table 1). Sixty of the subgroups
showed significant trend or non-linear change over time.
Significant increasing Pan-Europe trends over time
were identified in five anomaly subgroups (Fig. 2) of
which three were independent (hypospadias, renal dys-
plasia, and Edward syndrome/Trisomy 18) and two
were hierarchical subgroups reflecting the same trend
(anomalies of abdominal wall and its component sub-
group gastroschisis). All of these trends were identified
in the previous statistical monitoring report up to 2007
(EUROCAT, 2010b), and all showed significant individ-
ual registry results for between 2 and 5 of the 21 regis-
tries (Table 2). The rate of increase per 2-year interval
ranged from 2 to 6% (Table 1).
Decreasing Pan-Europe trends were detected in 36
anomaly subgroups with a decrease in rate per 2-year
interval of 2 to 17%, of which 22 were new decreasing
trends and 14 were ‘‘continuing’’ decreasing trends that
were identified in the previous statistical monitoring
report to 2007 (EUROCAT, 2010b). These included some
non-independent decreasing trends (e.g., trends in NTD
and two of its component subgroups, and trends in
severe congenital heart defects [CHD] and six of its com-
ponent subgroups). Twelve of the decreasing trends were
identified in four or more individual registries, (Table 2).
Pan-Europe analysis detected some decreasing trends in
subgroups where numbers in individual registries were
too small for analysis, such as anophthalmos and single
ventricle (Table 2). The largest percentage change tended
to be associated with heterogeneous organ system sub-
groups. Nineteen anomaly subgroups showed significant
Pan-Europe non-linear change (Table 1).
A total of 1190 chi-square tests were performed (Table
2) for the 21 individual registries across 96 subgroups
(plus adjusted Down syndrome analysis), of which 38%
returned ‘‘significant’’ results: 68 increasing trends, 201
decreasing trends, and 189 non-linear change. Tests were
not performed in 847 registry/anomaly combinations
(738 due to small numbers, 105 due to registry change
from ICD9–10 coding within the monitoring period, and
4 for adjusted Down syndrome analyses as registries had
no maternal age information for births in their region).
Eight anomaly subgroups were not tested in any registry
due to small numbers (Table 2).
The subgroup ‘‘All non-chromosomal anomalies’’
showed some sort of significant change in all individual
registries, whether increasing (2 registries), decreasing (8
registries), or non-linear change (11 registries).
The maximum number of subgroups showing increas-
ing trends per registry was nine (Table 2). The maximum
number of subgroups showing decreasing trends per
registry was 29 (Table 2).
Preliminary Investigations into Increasing and
Decreasing 10-year Trends
Registries were asked to investigate all individual
registry increasing trends (n 5 68), but discussion at the
Registry Leaders Meeting was particularly focused on
those that were significant at the Pan-Europe level, and
those that showed an increase in multiple registries.
Registry preliminary investigation reports were avail-
able for 62 of the 68 increasing trends (91%). Diagnostic
or data quality issues such as changes in case ascertain-
ment, definition and inclusion criteria, or diagnostic
methods accounted for 63% (n 5 39) of the increasing
trends. Registries reported that 11% of the increasing
trends were due to known demographic changes in
maternal age: gastroschisis (one registry), chromosomal
anomalies (one registry), Down syndrome/trisomy 21
(two registries, as shown by the non-significant adjusted
Down syndrome trend), Edward syndrome/trisomy 18
(two registries), and Klinefelter’s syndrome (one regis-
try). Local registry investigations are ongoing into five
increasing trends (8%) felt to be of concern in relation to
potential changes in teratogenic exposures: abdominal
wall defects, gastroschisis (which accounts for the ab-
dominal wall defects trend), genital anomalies, hypospa-
dias, and cleft lip with or without palate. Six percent of
trends were not confirmed locally as trends either did
not continue with the addition of more recent data or the
anomaly subgroup was considered too heterogeneous
(mainly major organ subgroups) for the trend to be of in-
terest. Registries reported that 11% (n 5 7) of increasing
trends could await further local surveillance. Four of the
seven were new trends, three of which were increasing
only in the registry.
Following Steering Committee review of the monitor-
ing results, five anomalies with decreasing trends
reported in four or more registries, as well as Pan-
Europe, were prioritized for investigation by the 13
registries involved (Fig. 3). Three of these were continu-
ing trends reported in the previous statistical monitoring
report (EUROCAT, 2010b; NTD, spina bifida, and hip
dislocation), for which investigations had not yet been
requested (the previous year registries had reported only
on increasing trends). Anorectal atresia showed a new
decreasing trend. Severe CHD as a new subgroup
combining 13 other cardiac subgroups was included in
monitoring for the first time in 2010.
Registry preliminary investigation reports were avail-
able from 11 of the 13 registries with one or more of the
selected decreasing trends. For NTD and its component
spina bifida, of six registries investigating trends, four
found no explanation and concluded the trend might be
real (given prior interest in folic acid), and two identified
Figure 2. Increasing trends detected in 5 specific congenital
anomalies across Europe 1999–2008.
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problems with the completeness or confirmation of data.
For severe CHD, two of four registries investigating
found no explanation, one was following up a coding
problem found, and another could not further confirm
cases due to data protection issues. For hip dislocation,
of four investigating registries, three reported known
changing screening and diagnostic systems in their
regions as a likely explanation, and one judged that there
had been a reporting change but noted that their rate
had been much higher than the EUROCAT average. For
anorectal atresia, of three registries reporting, two found
no explanation, and one noted again that their prevalence
had been much higher than the EUROCAT average.
DISCUSSION
We have reported a statistical monitoring system for
identifying potential trends in congenital anomaly preva-
lence in the EUROCAT network. This system has been
evolving over the last 5 years, and will continue to be
refined. It is likely that country will be introduced as an
intermediate level of analysis where there is more than
one registry per country, maternal age adjustment will
be added to the total chromosomal and Trisomy 13 and
18 subgroups, as is now done for Down syndrome, and
that the prioritization strategy will be more clearly
reflected in the presentation of results, including dis-
counting the major organ subgroups. We are working on
further refining the prioritization strategy and process,
and improving the consistency and coordination of
investigations across registries and centrally. Neverthe-
less, this is only a screening system for areas of concern
– where there is concern, more sophisticated statistical
analysis and investigation of exposure hypotheses is
done to take demographic heterogeneity across Europe
into account.
For four anomalies (contributing to five anomaly sub-
groups), there is consistent evidence of increasing trends.
The trend in gastroschisis is of continuing concern (Loane
et al., 2007), and although reported worldwide in the
past, it now seems to be particularly a U.K. phenomenon.
Trisomy 18 is under separate investigation in relation to
whether it can be explained by changes in maternal age,
and by earlier detection of cases detected antenatally,
which would otherwise not have survived to late preg-
nancy and diagnosis. The increase in hypospadias will be
investigated, particularly in relation to a change in defini-
tion in 2005 when glanular hypospadias was no longer
excluded as a minor anomaly. A study of renal dysplasia
is also in progress.
Decreasing trends, however, are much more common
than increasing trends, and overall this can possibly be
considered a ‘‘good news’’ story. In particular, evidence
that NTD (and its components subgroups spina bifida
and anencephaly) has recently started decreasing may
indicate an improvement in periconceptional folate status
(EUROCAT, 2009a). A decrease in severe CHD (and six
of its component CHD subgroups) has also been noted in
Canada (Prsa et al., 2009) and is under further investiga-
tion (Dolk et al., 2010, Dolk et al., in press, Khoshnood,
submitted for publication). Other trends across Europe,
including anorectal atresia, will be investigated. Some of
the rarer subgroups can only be feasibly investigated cen-
trally, and heterogeneity within some subgroups (such as
disorders of the skin) and coding issues in others are
being addressed. Meta-analysis techniques to investigate
the relationships between different anomaly subgroups
are possible, but we believe that more hypothesis-driven
investigations of relationships will probably prove more
fruitful, and we limit ourselves to observing the co-occur-
rence of trends in different subgroups, such as NTD and
severe CHD (Dolk et al., 2010).
Many trends in individual registries are found to result
from changes in case ascertainment by the registry due
to changes in sources of information, or changes in diag-
nostic methods or screening. The EUROCAT monitoring
system serves as a data quality monitoring system as
well as teratogen surveillance. Although investigation of
trends can be a time consuming task for registries, it is
an essential part of surveillance, whether or not a ‘‘true’’
underlying trend is found. Changing data quality causes
‘‘false-negative’’ results in the monitoring system where
real trends are not detected.
The test for trend used in this analysis operates under
the null hypothesis of no linear trend in the proportions.
The performance of the test for trend was compared
to binomial and Poisson regression as alternative
approaches. Using a subset of 434 registry/anomaly
combinations, the results of the test for trend and bino-
mial regression were in agreement in 82% of tests. Diver-
gence of results could not always be easily explained,
although differences frequently occurred when the
observed number of cases was below the minimum
required for the test for trend.
In the absence of an adjustment for multiple hypothesis
testing, it is clear that many spurious results will be
obtained. However, the test for trend is intended as a
screening tool and a high sensitivity is preferred at the
expense of a low specificity, followed up by a prioritization
strategy to focus on the anomalies of most interest within
the resources available for investigation. A lower p value
cutoff could have been chosen, but this would have very
little affect on the Pan-Europe results and of all significant
individual registry results, 72% were significant at p < 0.01.
A lower p value cutoff would tend to select even more of
the larger subgroups or larger registries.
The Pan-Europe analysis is a crude unweighted adding
of registries. It is difficult to implement any more sophis-
ticated statistical techniques as a routine screening tool,
for example, multilevel analysis with registries as ran-
dom effects because of the small numbers often encoun-
tered in individual congenital anomaly subgroups or
Figure 3. Decreasing trends detected in 5 specific congenital
anomaly subgroups across Europe 1999–2008.
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small registries. We are finding the crude tool adequate
for screening, with more sophisticated subsequent analy-
sis adapted to the frequency and characteristics of the
anomaly of concern. Currently, monitoring for 10-year
trends covers 600,000 births per year in Pan-Europe anal-
ysis, or 11% of EU births. This is not necessarily a repre-
sentative sample of the EU, and care needs to be taken in
extrapolation to the entire EU.
A central concern for surveillance is timeliness, although
this is less important for the detection of 10-year trends
than the detection of recent clusters. The Central Registry
receives data annually, allowing a year’s interval for diag-
nosis and ascertainment of cases, and performs monitoring
very shortly after data receipt. Individual registries can tai-
lor earlier monitoring to their own data collection proc-
esses, and the statistical analyses are programmed within
the common software (EDMP) with a user friendly inter-
face to facilitate this. The provision of software to member
registries is part of the ‘‘added value’’ of funded central
coordination. However, few registries have so far imple-
mented earlier monitoring EUROCAT, 2010b and indeed
some are not able to meet the central transmission dead-
line, although the number meeting the deadline has greatly
improved over recent years.
EUROCAT statistical monitoring allows an overview of
the situation in Europe, while providing ‘‘added value’’
to individual registries by setting their individual results
in a wider context. EUROCAT statistical monitoring has
evolved over time with annual discussion, review, and
refinement of the monitoring methodology and process.
A clearer designation of public health responsibilities and
pathways by which issues of potential public health con-
cern are acted upon are now needed.
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